Jacob M Hebert

Formulation Scientist at Vaccine Production Program/VRC/NIAID/NIH
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Boston

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Formulation Scientist
      • Mar 2023 - Present
    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • Sep 2016 - Present

      Designed and optimized targeted liposome drug delivery vehicles to promote vascular penetration and cellularly delivery to triple negative breast cancer cells.

    • Teaching Assistant
      • Sep 2016 - Apr 2022

      Supervised and instructed undergraduate students on the theory and operation of industrial heat exchangers, as well as chemical and physical separation equipment.

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Associate Researcher
      • Jan 2016 - May 2016

      Formulated novel therapeutic proteins using biophysical and chemical techniques to ensure long-term stability and efficacy of clinical products. Formulated novel therapeutic proteins using biophysical and chemical techniques to ensure long-term stability and efficacy of clinical products.

    • Canada
    • Advertising Services
    • 1 - 100 Employee
    • Associate Researcher
      • Jan 2015 - Dec 2015

      Developed methods for evaluating the wear of polymer materials for use in orthopedic arthroplasty. Developed methods for evaluating the wear of polymer materials for use in orthopedic arthroplasty.

Education

  • University of Maryland - A. James Clark School of Engineering
    Bachelor of Science - BS, Chemical and Biomolecular Engineering
    2011 - 2015
  • Northeastern University
    Doctor of Philosophy - PhD, Chemical Engineering
    2016 - 2022

Community

You need to have a working account to view this content. Click here to join now